Item(by='dragonwriter', descendants=None, kids=None, score=None, time=1608310456, title=None, item_type='comment', url=None, parent=25468877, text='&gt; Does this mean that the research basically was about creating sort of like a &quot;template&quot; vaccine that can then be specialised or programmed with the specifics of the thing you&#x27;re trying to vaccinate against?<p>That may (or may not) have been the effect (at least within a narrow family of similar viruses), and is definitely something they market about their “mRNA platform”, but their immediately-previous mRNA vaccine work which was ongoing when they shifted to SARS-CoV-2, was specifically directed at MERS-CoV, another very similar betacoronavirus of significant public health impact (though a lot less widespread than SARS-CoV-2 has become.)')